Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Cardiotoxicity of doxorubicin and other anthracycline derivatives
2000
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Somatostatin and Somatostatin Receptor Subtype Gene Expression in Medullary Thyroid Carcinoma1
1998
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively
2013
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
Fine‐motor skill deficits in childhood predict adulthood tic severity and global psychosocial functioning in Tourette's syndrome
2005
Delirium in elderly people
2013 Standout
Cognitive modulation of pain: how do attention and emotion influence pain processing?
2002 Standout
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion
2005 Standout
Cerebral Perfusion Changes in Older Delirious Patients Using 99mTc HMPAO SPECT
2006
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Noninvasive Imaging in Myocarditis
2006
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective
2005 Standout
The Neural Basis of Addiction: A Pathology of Motivation and Choice
2005 Standout
Endogenous opiates: 1999
2000
Addiction Motivation Reformulated: An Affective Processing Model of Negative Reinforcement.
2004 Standout
Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
2009 Standout
Localization of Medullary Thyroid Carcinoma Metastasis in a Multiple Endocrine Neoplasia Type 2A Patient by 6-[18F]-Fluorodopamine Positron Emission Tomography
2003
Cardiovascular toxicity caused by cancer treatment: strategies for early detection
2009
Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex
2001 Standout
Myocarditis
2011 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
Clinical Pharmacokinetics of Tacrolimus
1995 Standout
Treatment of medullary thyroid carcinoma: an update.
2001
Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies
2008 Standout
Monitoring chemotherapy-induced cardiotoxicity: Role of cardiac nuclear imaging
2006
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT
2009
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Indium-111 monoclonal antimyosin cardiac scintigraphy in suspected acute myocarditis: evolution and diagnostic impact
2003
The cognitive control of emotion
2005 Standout
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac risk
2009
Imaginary Relish and Exquisite Torture: The Elaborated Intrusion Theory of Desire.
2005 Standout
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
2003
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Predicting Mortality Among Patients Hospitalized for Heart Failure
2003 Standout
Regulation of cardiac hypertrophy by intracellular signalling pathways
2006 Standout
Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study
1999
Neurocircuitry of Addiction
2009 Standout
Neurobiology of addiction: a neurocircuitry analysis
2016 Standout
Tissue‐specific mtDNA lesions and radical‐associated mitochondrial dysfunction in human hearts exposed to doxorubicin
2005
Preservation of Fertility in Patients with Cancer
2009 Standout
Human viral cardiomyopathy
2003
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue
1995
Myocarditis
2006 Standout
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Anthracycline cardiotoxicity
2006
Addiction, a Disease of Compulsion and Drive: Involvement of the Orbitofrontal Cortex
2000
Vision assessment using the NIH Toolbox
2013 Standout
Gene-Targeted Mice Lacking the Trex1 (DNase III) 3′→5′ DNA Exonuclease Develop Inflammatory Myocarditis
2004 StandoutNobel
Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
2001
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
Guidelines for the management of thyroid cancer
2014 Standout
Determinative Factors of Biochemical Cure after Primary and Reoperative Surgery for Sporadic Medullary Thyroid Carcinoma
1998
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Thyroid carcinoma
2003 Standout
Works of L Bernà being referenced
Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
1993
111In-Octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma
1995
Detection of doxorubicin cardiotoxicity in patients with sarcomas by indium-111-antimyosin monoclonal antibody studies.
1993
Percentage of portal contribution to hepatic blood flow: utility in liver graft monitoring.
1987
Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy.
2000
Presence, evolving changes, and prognostic implications of myocardial damage detected in idiopathic and alcoholic dilated cardiomyopathy by 111In monoclonal antimyosin antibodies.
1994
Regional cerebral blood flow changes in chronic alcoholic patients induced by naltrexone challenge during detoxification.
1999